Literature DB >> 10982834

Natural killer cells and mast cells from gp49B null mutant mice are functional.

S Rojo1, C C Stebbins, M E Peterson, D Dombrowicz, N Wagtmann, E O Long.   

Abstract

Immune responses are controlled by a combination of positive and negative cellular signals. Effector cells in the immune system express inhibitory receptors that serve to limit effector cell expansion and to protect the host from autoreactivity. gp49B is a receptor of unknown function that is expressed on activated mast cells and natural killer (NK) cells and whose cytoplasmic tail endows it with inhibitory potential. To gain insight into the function of gp49B in mice, we disrupted the gp49B gene by homologous recombination. gp49B(0) mice were born at expected ratios, were healthy and fertile, and displayed normal long-term survival rates. gp49B(0) mice showed no defect in NK or mast cell development. Furthermore, NK and mast cells from the gp49B(0) mice showed activation properties in vitro similar to those of cells isolated from wild-type mice. Therefore, gp49B is not critical for the development, expansion, and maturation of mast cells and NK cells in vivo. The healthy status of gp49B(0) mice makes them suitable for testing the role of gp49B in immune responses to infectious agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982834      PMCID: PMC86271          DOI: 10.1128/MCB.20.19.7178-7182.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  17 in total

1.  A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor.

Authors:  N Hirasawa; A Scharenberg; H Yamamura; M A Beaven; J P Kinet
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

2.  Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.

Authors:  N Wagtmann; S Rajagopalan; C C Winter; M Peruzzi; E O Long
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

Review 3.  NK cell receptors.

Authors:  L L Lanier
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 4.  A newly recognized pathway for the negative regulation of mast cell-dependent hypersensitivity and inflammation mediated by an endogenous cell surface receptor of the gp49 family.

Authors:  H R Katz; K F Austen
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

5.  Inducible expression of the gp49B inhibitory receptor on NK cells.

Authors:  L L Wang; D T Chu; A O Dokun; W M Yokoyama
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

6.  The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice.

Authors:  J R Dorfman; J Zerrahn; M C Coles; D H Raulet
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

7.  Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells.

Authors:  S Rojo; D N Burshtyn; E O Long; N Wagtmann
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

8.  Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors.

Authors:  L L Wang; I K Mehta; P A LeBlanc; W M Yokoyama
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

9.  Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene.

Authors:  A Kuroiwa; Y Yamashita; M Inui; T Yuasa; M Ono; A Nagabukuro; Y Matsuda; T Takai
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

10.  gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization.

Authors:  J M Lu-Kuo; D M Joyal; K F Austen; H R Katz
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

View more
  6 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice.

Authors:  M Daheshia; D S Friend; M J Grusby; K F Austen; H R Katz
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

Review 3.  Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Authors:  Mi Deng; Heyu Chen; Xiaoye Liu; Ryan Huang; Yubo He; Byounggyu Yoo; Jingjing Xie; Samuel John; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Antib Ther       Date:  2021-02-09

4.  NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice.

Authors:  Ha-Na Lee; Mohanraj Manangeeswaran; Aaron P Lewkowicz; Kaliroi Engel; Monica Chowdhury; Mamatha Garige; Michael A Eckhaus; Carole Sourbier; Derek Dc Ireland; Daniela Verthelyi
Journal:  JCI Insight       Date:  2022-02-08

Review 5.  Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.

Authors:  Xunlei Kang; Jaehyup Kim; Mi Deng; Samuel John; Heyu Chen; Guojin Wu; Hiep Phan; Cheng Cheng Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

6.  Decidual Macrophage Functional Polarization during Abnormal Pregnancy due to Toxoplasma gondii: Role for LILRB4.

Authors:  Zhidan Li; Mingdong Zhao; Teng Li; Jing Zheng; Xianbing Liu; Yuzhu Jiang; Haixia Zhang; Xuemei Hu
Journal:  Front Immunol       Date:  2017-08-24       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.